DAIC

OCTOBER 16, 2024

15 , 2024 — Four of the seven Medicare Administrative Contractors (MACs) have released final local coverage determinations (LCD) for AI-Coronary Plaque Analysis (AI-CPA). The SCCT HPPC offers tools for administrators to navigate the complex landscape of insurance plans, billing and reimbursement on SCCT website, scct.org.

CMS 52

CMS Medicare Plaque Chest Pain 52

American College of Cardiology

FEBRUARY 1, 2025

In today's health care landscape, where quality metrics tied to reimbursement have become the standard, clinicians are under increasing pressure to prescribe specific medications. Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease. J Am Geriatr Soc. 2023;71(7): 2052-2081.

Cardiovascular Disease 40

Cardiovascular Disease Coronary Artery Disease CMS Hospital 40

DAIC

MARCH 28, 2025

CCTA offers a non-invasive, cost-effective, and highly sensitive method for diagnosing coronary artery disease (CAD), making it a valuable tool for clinicians. vii Similarly, recent increases in Medicare reimbursement rates for CCTA are a positive step towards making this technology more accessible. link] iv IMV.2023

Technology 59

Technology Coronary Artery Disease Atrial Fibrillation Medicare 59

DAIC

MARCH 3, 2025

25, 2025 GE HealthCare has delivered the first patient doses of Flyrcado(flurpiridaz F 18) injection, a unit dose positron emission tomography myocardial perfusion imaging (PET MPI) agent for detecting coronary artery disease (CAD), at early adopter imaging centers in the US. tim.hodson Mon, 03/03/2025 - 16:07 Feb.

Coronary Artery Disease 52

Coronary Artery Disease Ischemia Exercise Hospital 52